RESUMEN
A major controversy regarding Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) is whether or not it is a ubiquitous infection of humans. Immunoassays based on KSHV- and Epstein-Barr virus (EBV)-coinfected cell lines show that most US AIDS-KS patients have specific antibodies to KSHV-related antigens. We have developed a sensitive indirect immunofluorescence assay (IFA) based on an EBV-negative, KSHV-infected cell line, BCP-1. When we used this IFA assay, KSHV-related antibodies were found in 71-88% of serum samples from US, Italian and Ugandan AIDS-KS patients, as well as all serum samples examined from HIV-seronegative KS patients. Although none of the US blood donors examined were KSHV seropositive by IFA, intermediate and high seroprevalence rates were found in Italian and Ugandan control populations. Antibody kinetics showed that more than half of the AIDS-KS patients who were examined IgG-seroconverted before KS development, and antibody levels did not decline after seroconversion. For these patients, seropositivity rates increased linearly with time, suggesting that the rate of infection was constant and that the risk of developing KS once infected with KSHV is not highly dependent on the duration of infection. These data strongly suggest that KSHV is not ubiquitous in most populations and that the virus may be under strict immunologic control in healthy KSHV-infected persons.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/virología , Anticuerpos Antivirales/análisis , Herpesviridae/inmunología , Sarcoma de Kaposi/virología , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Infecciones Oportunistas Relacionadas con el SIDA/inmunología , Estudios de Casos y Controles , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Italia/epidemiología , Masculino , Sarcoma de Kaposi/epidemiología , Sarcoma de Kaposi/inmunología , Uganda/epidemiología , Estados Unidos/epidemiologíaRESUMEN
Four virus proteins similar to two human macrophage inflammatory protein (MIP) chemokines, interleukin-6 (IL-6), and interferon regulatory factor (IRF) are encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV) genome. vIL-6 was functional in B9 proliferation assays and primarily expressed in KSHV-infected hematopoietic cells rather than KS lesions. HIV-1 transmission studies showed that vMIP-I is similar to human MIP chemokines in its ability to inhibit replication of HIV-1 strains dependent on the CCR5 co-receptor. These viral genes may form part of the response to host defenses contributing to virus-induced neoplasia and may have relevance to KSHV and HIV-I interactions.
Asunto(s)
Herpesvirus Humano 8/genética , Imitación Molecular , Proteínas no Estructurales Virales/genética , Secuencia de Aminoácidos , Animales , División Celular , Línea Celular , Quimiocina CCL4 , Expresión Génica , Genes Virales , VIH-1/fisiología , Herpesvirus Humano 4/fisiología , Herpesvirus Humano 8/fisiología , Humanos , Interleucina-6/química , Interleucina-6/genética , Ganglios Linfáticos/virología , Linfoma de Células B/virología , Proteínas Inflamatorias de Macrófagos/química , Proteínas Inflamatorias de Macrófagos/genética , Ratones , Datos de Secuencia Molecular , Receptores CCR5 , Receptores de Citocinas/metabolismo , Receptores del VIH/metabolismo , Sarcoma de Kaposi/virología , Alineación de Secuencia , Transducción de Señal , Acetato de Tetradecanoilforbol/farmacología , Células Tumorales Cultivadas , Proteínas no Estructurales Virales/química , Proteínas no Estructurales Virales/fisiología , Replicación ViralRESUMEN
Representational difference analysis was used to isolate unique sequences present in more than 90 percent of Kaposi's sarcoma (KS) tissues obtained from patients with acquired immunodeficiency syndrome (AIDS). These sequences were not present in tissue DNA from non-AIDS patients, but were present in 15 percent of non-KS tissue DNA samples from AIDS patients. The sequences are homologous to, but distinct from, capsid and tegument protein genes of the Gammaherpesvirinae, herpesvirus saimiri and Epstein-Barr virus. These KS-associated herpesvirus-like (KSHV) sequences appear to define a new human herpesvirus.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , ADN Viral/análisis , Herpesviridae/genética , Sarcoma de Kaposi/virología , Secuencia de Aminoácidos , Composición de Base , Secuencia de Bases , Southern Blotting , Clonación Molecular , ADN Viral/química , ADN Viral/genética , Femenino , Herpesvirus Saimiriino 2/genética , Herpesvirus Humano 4/genética , Humanos , Masculino , Datos de Secuencia Molecular , Hibridación de Ácido Nucleico , Sistemas de Lectura Abierta , Reacción en Cadena de la Polimerasa , Estudios Retrospectivos , Sarcoma de Kaposi/etiología , Homología de Secuencia de AminoácidoRESUMEN
Unique among known human herpesviruses, Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) encodes chemokine-like proteins (vMIP-I and vMIP-II). vMIP-II was shown to block infection of human immunodeficiency virus-type 1 (HIV-1) on a CD4-positive cell line expressing CCR3 and to a lesser extent on one expressing CCR5, whereas both vMIP-I and vMIP-II partially inhibited HIV infection of peripheral blood mononuclear cells. Like eotaxin, vMIP-II activated and chemoattracted human eosinophils by way of CCR3. vMIP-I and vMIP-II, but not cellular MIP-1alpha or RANTES, were highly angiogenic in the chorioallantoic assay, suggesting a possible pathogenic role in Kaposi's sarcoma.
Asunto(s)
Quimiocinas/fisiología , VIH-1/fisiología , Herpesvirus Humano 8/genética , Proteínas Inflamatorias de Macrófagos/fisiología , Neovascularización Patológica/etiología , Receptores de Quimiocina , Proteínas Virales , Animales , Linfocitos T CD4-Positivos/virología , Quimiocinas/genética , Quimiocinas/metabolismo , Quimiocinas/farmacología , Quimiotaxis de Leucocito , Embrión de Pollo , Eosinófilos/fisiología , Herpesvirus Humano 8/fisiología , Humanos , Leucocitos Mononucleares/virología , Proteínas Inflamatorias de Macrófagos/genética , Proteínas Inflamatorias de Macrófagos/metabolismo , Proteínas Inflamatorias de Macrófagos/farmacología , Neutrófilos/fisiología , Receptores CCR3 , Receptores de Citocinas/agonistas , Receptores de Citocinas/metabolismo , Receptores del VIH/metabolismo , Células Tumorales Cultivadas , Replicación ViralRESUMEN
OBJECTIVE: Limited data are available on extended (EX) donor criteria in pancreatic transplantation (PTX). METHODS: This retrospective study from February 2007 through April 2007 compared 2 cohorts of simultaneous kidney-pancreas transplantations (SKPT): the first from EX donors, which were defined as age <10 years or > or =45 years, or donation after cardiac death [DCD]), and the second from conventional (CONV) donors. RESULTS: Among 79 SKPT, 19 (24%) were from EX donors (12 older than age 45 [mean age, 50.2 years], 3 pediatric donors <10, and 4 DCD donors) and the remaining 60 SKPT from CONV donors. The mean donor age was higher in EX than CONV donors (38 vs 25 years, P < .05). There were no other differences between the 2 cohorts. With a similar median follow-up of 29 months, patient, kidney and pancreatic graft survival rates were 89%, 89%, and 79%, for the EX, whereas corresponding outcomes for CONV donors were 93%, 87%, and 80%, respectively (all P = NS). The incidences were similar for delayed kidney graft function (5% in each group), early pancreatic graft loss due to thrombosis (5% EX vs 8% CONV donors), acute rejection (16% EX vs 18% CONV donors), surgical complications, and infections. There were no significant differences in 1-year mean serum creatinine (1.4 mg/dL in each group) or glycohemoglobin (5.2% vs 5.5%) levels between the EX and CONV donor groups, respectively. CONCLUSION: Short-term outcomes among SKPT from selected EX donors were comparable to CONV donors. Donors at the extremes of age and DCD donors may represent underused resources in SKPT.
Asunto(s)
Trasplante de Riñón , Trasplante de Páncreas/métodos , Sistema Porta , Donantes de Tejidos , Adolescente , Adulto , Niño , Estudios de Cohortes , Muerte , Drenaje/métodos , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Listas de EsperaRESUMEN
A common feature of many tumor viruses is that they possess genes that produce specific proteins to inhibit major cellular tumor-suppressor pathways. Despite intensive studies, the reasons why these diverse and unrelated viruses have independently evolved oncogenes remains obscure. Kaposi-sarcoma-associated herpesvirus (KSHV or HHV8) has pirated a number of recognizable cellular genes that are key to cell survival and proliferation. In this review, we provide an overview of the known activities of these viral genes and show that many of these pirated proteins affect the same cellular pathways targeted by other, unrelated tumor viruses. We speculate that tumor-suppressor pathways are used by the cell as a primary defense against persistent virus infection, in addition to their well-known activity in regulating cell proliferation.
Asunto(s)
Carcinógenos , Genes Supresores de Tumor , Genes Virales , Herpesvirus Humano 8/genética , Animales , Humanos , Interferones/metabolismo , Transducción de SeñalRESUMEN
The formation of a bipolar mitotic spindle is an essential process for the equal segregation of duplicated DNA into two daughter cells during mitosis. As a result of deregulated cellular signaling pathways, cancer cells often suffer a loss of genome integrity that might etiologically contribute to carcinogenesis. Merkel cell polyomavirus (MCV) small T (sT) oncoprotein induces centrosome overduplication, aneuploidy, chromosome breakage and the formation of micronuclei by targeting cellular ligases through a sT domain that also inhibits MCV large T oncoprotein turnover. These results provide important insight as to how centrosome number and chromosomal stability can be affected by the E3 ligase targeting capacity of viral oncoproteins such as MCV sT, which may contribute to Merkel cell carcinogenesis.
Asunto(s)
Antígenos Transformadores de Poliomavirus/metabolismo , Inestabilidad Genómica , Poliomavirus de Células de Merkel/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo , Animales , Antígenos Transformadores de Poliomavirus/genética , Línea Celular , Transformación Celular Neoplásica/genética , Centrosoma/metabolismo , Centrosoma/virología , Células HCT116 , Células HEK293 , Interacciones Huésped-Patógeno , Humanos , Células de Merkel/metabolismo , Células de Merkel/virología , Poliomavirus de Células de Merkel/genética , Poliomavirus de Células de Merkel/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Células 3T3 NIHRESUMEN
This corrects the article DOI: 10.1038/onc.2017.277.
RESUMEN
A high resolution allelotype for nonfunctional pancreatic endocrine tumors (NF-PETs) has been generated by microsatellite analysis of DNA from 16 frozen cases, each probed with 394 markers. Two subgroups of NF-PETs were found. Seven cases showed frequent, large allelic deletions [loss of heterozygosity (LOH)] with an average fractional allelic loss (FAL) of 0.55, whereas nine cases showed a small number of random losses with a FAL of 0.15. Designated high or low FAL, respectively, these genetic phenotypes showed correlation with the ploidy status: high-FAL tumors were aneuploid, low-FAL were diploid. Chromosomes 6q and 11q showed LOH in >60% of cases. About 50% of cases had losses on 11p, 20q, and 21. Selected LOH analysis on an additional 16 paraffin-embedded NF-PETs confirmed the high frequency of 6q and 11q LOH. The allelotype of NF-PET is markedly different from that of either ductal or acinar tumors of the pancreas as well as from that of functional-PETs. Moreover, whereas deletions involving chromosome 11 also are a feature of functional-PETs, the involvement of chromosome 6q is characteristic of NF-PETs. Survival analysis showed that none of the single chromosomal alterations was associated with outcome, whereas ploidy status is an independent factor adding prognostic information to that furnished by the proliferative index measured by Ki-67 immunohistochemistry.
Asunto(s)
Adenoma de Células de los Islotes Pancreáticos/genética , Pérdida de Heterocigocidad , Neoplasias Pancreáticas/genética , Adulto , Anciano , Análisis de Varianza , Deleción Cromosómica , ADN de Neoplasias/genética , Femenino , Humanos , Masculino , Repeticiones de Microsatélite , Persona de Mediana Edad , Neoplasia Endocrina Múltiple Tipo 1/genética , Análisis Multivariante , Ploidias , Análisis de SupervivenciaRESUMEN
Kaposi's sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus linked to the development of Kaposi's sarcoma and a rare B cell lymphoma, primary effusion lymphoma. The KSHV gene ORF K9 encodes vIRF which is a protein with low but significant homology to members of the interferon (IFN) regulatory factor (IRF) family responsible for regulating intracellular interferon signal transduction (Moore PS, Boshoff C, Weiss RA and Chang Y. (1996). Science, 274, 1739-1744). vIRF inhibits IFN-beta signal transduction as measured using an IFN-responsive ISG54 reporter construct co-transfected with ORF K9 into HeLa and 293 cells. vIRF also suppresses genes under IFN regulatory control as shown by inhibition of the IFN-beta inducibility of p21WAF1/CIP1, however, no direct DNA-binding or protein-protein interactions characteristic for IRF repressor proteins were identified. Stable transfectant NIH3T3 clones expressing vIRF grew in soft agar and at low serum concentrations, lost contact inhibition and formed tumors after injection into nude mice indicating that vIRF has the properties of a viral oncogene. Since vIRF is primarily expressed in KSHV-infected B cells, not KS spindle cells, this study suggests that vIRF is a transforming oncogene active in B cell neoplasias that may provide a unique immune escape mechanism for infected cells. This data is consistent with tumor suppressor pathways serving a dual function as host cell antiviral pathways.
Asunto(s)
Herpesvirus Humano 8/genética , Interferones/metabolismo , Oncogenes , Transducción de Señal/genética , Células 3T3 , Animales , Transformación Celular Viral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/genética , Regulación de la Expresión Génica/genética , Genes Reporteros , Interferones/genética , RatonesRESUMEN
Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, the most recently discovered human tumor virus, is involved in the pathogenesis of Kaposi's sarcoma, primary effusion lymphoma and some cases of multicentric Castleman's disease. It is non-pathogenic in the majority of otherwise healthy individuals but highly oncogenic in the context of HIV-1 infection and iatrogenic immune suppression, and other cofactors might exist. Several viral genes can interfere with normal cell growth and differentiation, but their precise role in oncogenesis is still under investigation.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/virología , Herpesvirus Humano 8/patogenicidad , Sarcoma de Kaposi/virología , Enfermedad de Castleman/etiología , Enfermedad de Castleman/virología , Diferenciación Celular , División Celular , Genes Virales/fisiología , Herpesvirus Humano 8/clasificación , Herpesvirus Humano 8/genética , Humanos , Huésped Inmunocomprometido , Linfoma/etiología , Linfoma/virología , Virus Oncogénicos/patogenicidad , Sarcoma de Kaposi/complicacionesRESUMEN
The antagonizing action of hydrostatic pressure against anesthesia is well known. The present study was undertaken to quantitate the effects of hydrostatic pressure and anesthetics upon the phase-transition temperature of dipalmitoyl phosphatidylcholine vesicles. The drugs used to anesthetize the phospholipid vesicles included an inhalation anesthetic, halothane, a dissociable local anesthetic, lidocaine and an undissociable local anesthetic, benzyl alcohol. All anesthetics decreased the phase-transition temperature dose-dependently. In the case of lidocaine, the depression was pH dependent and only uncharged molecules were effective. The application of hydrostatic pressure increased the phase-transition temperature both in the presence and the absence of anesthetics. The temperature-pressure relationship was linear over the entire pressure range studied up to 340 bars. Through the use of Clapeyron-Clausius equation, the volume change accompanying the phase-transition of the membrane was calculated to be 27.0 cm3/mol. Although the anesthetics decreased the phase-transition temperature, the molar volume change accompanying the phase-transition was not altered. The anesthetics displaced the temperature-pressure lines parallel to each other. The mole fraction of the anesthetics in the liquid crystalline membrane, calculated from the van't Hoff equation, was independent of pressure. This implies that pressure does not displace the anesthetics from the liquid membrane, and the partition of these agents remains constant. The volume change of the anesthetized phospholipid membranes is entirely dependent upon the phase-transition and not on the space occupied by the anesthetics.
Asunto(s)
Anestésicos , Presión Hidrostática , Liposomas , Presión , Surfactantes Pulmonares , Halotano , Lidocaína , TermodinámicaRESUMEN
Molecular analysis of CCR5, the cardinal coreceptor for HIV-1 infection, has implicated the N-terminal extracellular domain (N-ter) and regions vicinal to the second extracellular loop (ECL2) in this activity. It was shown that residues in the N-ter are necessary for binding of the physiologic ligands, RANTES (CCL5) and MIP-1 alpha (CCL3). vMIP-II, encoded by the Kaposi's sarcoma-associated herpesvirus, is a high affinity CCR5 antagonist, but lacks efficacy as a coreceptor inhibitor. Therefore, we compared the mechanism for engagement by vMIP-II of CCR5 to its interaction with physiologic ligands. RANTES, MIP-1 alpha, and vMIP-II bound CCR5 at high affinity, but demonstrated partial cross-competition. Characterization of 15 CCR5 alanine scanning mutants of charged extracellular amino acids revealed that alteration of acidic residues in the distal N-ter abrogated binding of RANTES, MIP-1 alpha, and vMIP-II. Whereas mutation of residues in ECL2 of CCR5 dramatically reduced the binding of RANTES and MIP-1 alpha and their ability to induce signaling, interaction with vMIP-II was not altered by any mutation in the exoloops of the receptor. Paradoxically, monoclonal antibodies to N-ter epitopes did not block chemokine binding, but those mapped to ECL2 were effective inhibitors. A CCR5 chimera with the distal N-ter residues of CXCR2 bound MIP-1 alpha and vMIP-II with an affinity similar to that of the wild-type receptor. Engagement of CCR5 by vMIP-II, but not RANTES or MIP-1 alpha blocked the binding of monoclonal antibodies to the receptor, providing additional evidence for a distinct mechanism for viral chemokine binding. Analysis of the coreceptor activity of randomly generated mouse-human CCR5 chimeras implicated residues in ECL2 between H173 and V197 in this function. RANTES, but not vMIP-II blocked CCR5 M-tropic coreceptor activity in the fusion assay. The insensitivity of vMIP-II binding to mutations in ECL2 provides a potential rationale to its inefficiency as an antagonist of CCR5 coreceptor activity. These findings suggest that the molecular anatomy of CCR5 binding plays a critical role in antagonism of coreceptor activity.
Asunto(s)
Quimiocina CCL5/metabolismo , Quimiocinas/metabolismo , VIH-1/metabolismo , Proteínas Inflamatorias de Macrófagos/metabolismo , Receptores CCR5/química , Receptores CCR5/metabolismo , Proteínas del Envoltorio Viral/metabolismo , Alanina/genética , Alanina/metabolismo , Sustitución de Aminoácidos , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , Unión Competitiva , Antagonistas de los Receptores CCR5 , Células CHO , Quimiocina CCL3 , Quimiocina CCL4 , Quimiocina CCL5/antagonistas & inhibidores , Quimiocinas/antagonistas & inhibidores , Quimiocinas/química , Cricetinae , Glicoproteínas/metabolismo , Humanos , Ligandos , Proteínas Inflamatorias de Macrófagos/antagonistas & inhibidores , Ratones , Modelos Moleculares , Mutación , Unión Proteica/efectos de los fármacos , Estructura Terciaria de Proteína , Receptores CCR5/genética , Proteínas Recombinantes de Fusión/antagonistas & inhibidores , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transducción de Señal , Relación Estructura-Actividad , Especificidad por Sustrato , Células Tumorales CultivadasRESUMEN
AIDS-related non-Hodgkin lymphomas (AIDS-NHL) are most frequently derived from B cells and include small non-cleaved cell lymphoma (SNCCL) and diffuse large cell lymphoma (DLCL) and less frequently anaplastic large cell lymphoma (ALCL) or body cavity-based lymphoma (BCBL). AIDS-NHL cell lines have proved useful to study AIDS-NHL pathogenesis. In this report, we describe the establishment and molecular characterization of two novel AIDS-NHL cell lines (HBL-4 and HBL-6) derived from lymphomatous effusions. HBL-4 was derived from a patient with SNCCL, whereas HBL-6 was derived from a patient with BCBL. The identity of the cell lines with the original tumor clone was established by immunoglobulin gene rearrangement analysis. Both HBL-4 and HBL-6 carry a monoclonal EBV infection and do not contain HIV. In addition, HBL-6 harbors DNA sequences of the recently identified Kaposi's sarcoma-associated herpesvirus (KSHV), now formally called human herpesvirus 8 (HHV8). Finally, HBL-4, but not HBL-6, harbors a rearranged c-MYC allele, while the BCL-6 gene displayed a germline configurations in both cell lines. These AIDS-NHL cell lines may prove useful in understanding the biologic events contributing to AIDS-NHL development.
Asunto(s)
Líquido Ascítico/patología , Linfoma Relacionado con SIDA/patología , Secuencia de Bases , Reordenamiento Génico , Reordenamiento Génico de Linfocito B , Genes myc , Herpesviridae/aislamiento & purificación , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Linfoma Relacionado con SIDA/genética , Linfoma Relacionado con SIDA/virología , Linfoma no Hodgkin/genética , Linfoma no Hodgkin/patología , Linfoma no Hodgkin/virología , Datos de Secuencia Molecular , Células Tumorales CultivadasRESUMEN
Tyrosine aminotransferase (TAT) is a liver-specific enzyme whose activity is subject to positive regulation by several agents including insulin and agonists that increase the intracellular concentration of cAMP. To further characterize the mechanism of insulin action and the interaction between cAMP and insulin several types of experiments were performed in a rat hepatoma cell-line. In the presence of the transcriptional inhibitor 5,6-dichloro-1-beta-D-ribofuranoyslbenzimidazole, TAT enzyme activity remains inducible by insulin and to a lesser extent by the cAMP analog (Bu)2cAMP. This suggests that transcriptional events are not necessary for the insulin-mediated increase in TAT activity, and also suggests a dualistic mechanism for the cAMP-induced increase in TAT activity. Surprisingly, using a cDNA probe for mRNATAT, it was found that insulin causes a decrease in hybridizable mRNATAT, in addition to causing a partial inhibition of the increase of hybridizable TAT transcript caused by (Bu)2cAMP. Examination of the rate of transcription of the TAT gene by a nuclear run-off assay shows that insulin causes a decrease in the transcription of the TAT gene by greater than 50%, which is sufficient to account for the decrease in hybridizable mRNATAT. As expected (Bu)2cAMP increases the transcription of TAT, but combined with insulin a complete inhibition of the increase in TAT transcription caused by (Bu)2cAMP is observed. To address the possibility that insulin acts posttranslationally to increase TAT activity, the t1/2 of TAT protein was measured in the presence and absence of insulin.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
AMP Cíclico/farmacología , Insulina/farmacología , Transcripción Genética/efectos de los fármacos , Tirosina Transaminasa/metabolismo , Animales , Bucladesina/farmacología , Diclororribofuranosil Benzoimidazol/farmacología , Interacciones Farmacológicas , Activación Enzimática/efectos de los fármacos , Inducción Enzimática/efectos de los fármacos , Neoplasias Hepáticas Experimentales , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Células Tumorales Cultivadas , Tirosina Transaminasa/genéticaRESUMEN
BACKGROUND: Endemic Kaposi's sarcoma (KS) is a clinically and epidemiologically distinct human immunodeficiency virus negative form of KS occurring in Africa. Kaposi's sarcoma is now the most frequently reported cancer in some areas of Africa. OBJECTIVE: To determine if a KS-associated herpesvirus (KSHV) is present in both endemic HIV-seronegative and HIV-seropositive KS lesions from African patients. METHODS: Paraffin-embedded tissue specimens from Ugandan patients with KS and non-KS tumor control patients attending a university-based oncology clinic were examined in a blinded case-control study. Tissue DNA specimens were examined for detectable KSHV genome by nested polymerase chain reaction performed at two independent laboratories. RESULTS: We identified KSHV in 17 (85%) of 20 KS tissue specimens from HIV-seronegative patients and 22 (92%) of 24 KS tissue specimens from HIV-infected persons. Kaposi's sarcoma lesions from four HIV-infected persons and four HIV-seronegative persons were positive for KSHV. Unlike previous studies in North America and Europe, three (14%) of 22 non-KS cancer control patients' tissue specimens were also positive for KSHV that resulted in an overall odds ratio of 49.2 (95% confidence interval, 9.1 to 335) for detecting KSHV in KS lesions from patients in Uganda. CONCLUSION: As in North America and Europe, KSHV infection is strongly associated with both HIV-seropositive and HIV-seronegative KS in Africa. However, it is likely that infection with this virus is more highly prevalent in Uganda.
Asunto(s)
Seropositividad para VIH/complicaciones , Herpesviridae/aislamiento & purificación , Sarcoma de Kaposi/virología , Estudios de Casos y Controles , ADN Viral/aislamiento & purificación , Seronegatividad para VIH , Herpesviridae/genética , Humanos , Oportunidad Relativa , Reacción en Cadena de la Polimerasa , Método Simple Ciego , UgandaRESUMEN
We compared glycosylated hemoglobin (GHb) determined from capillary blood samples on paper strips with a standard microcolumn technique in a cross-sectional observational study with laboratories blinded to duplicate samples. Both the standard and the filter strip laboratories were provided with 80 uniquely identified blood samples from 40 individuals. Each laboratory ran duplicate analyses on each sample, yielding 160 GHb values. The within-laboratory correlations between blinded duplicates were 0.98 for the standard (microcolumn technique) and 0.94 for the filter paper (affinity technique) laboratories. The between-laboratory correlations ranged from 0.69 to 0.77. When classifying patients by quartile of glycemic control, the laboratories agreed on 60% of the patients. In an effort to identify sources of between-laboratory variability, varying quantities of blood were applied to strips and reanalyzed. Five microliter drops always yielded inflated estimates of GHb. These data suggest that the estimates of GHb obtained from mail-in paper strips, although internally consistent, differ in important ways from standard laboratory values, reemphasizing the need for caution in the interpretation of interlaboratory and intermethod comparisons.
Asunto(s)
Automonitorización de la Glucosa Sanguínea/métodos , Hemoglobina Glucada/análisis , Humanos , Tiras ReactivasRESUMEN
Unraveling the mysteries associated with the etiology of KS is of tremendous public health significance. Whereas the introduction of prophylaxis has led to a decreased incidence of Pneumocystis carinii pneumonia, the incidence of KS has remained relatively stable and treatment of the HIV-infected KS patient remains a challenge. The last year has brought forth significant breakthroughs in KS research. Although KSHV has only recently been described, rapid progress is being made in understanding the role of this virus in the pathophysiology of the various forms of KS. It is too early to conclude whether KSHV is the elusive 'KS cofactor' or if all forms of KS share a common etiology, but it appears to be the single most plausible agent to be identified to date. Since all cancers are multifactorial in origin, it is likely that other host, environmental and possibly other viral cofactors could influence the risk of developing KS. The search for such cofactors must continue. Even if KSHV plays a central role, the exact mechanisms by which HIV and KSHV may interact to induce KS lesions, the tendency for KS to occur among homosexual men relative to other HIV transmission groups, and the reasons for the aggressive course of this neoplasm in HIV-infected persons remain to be determined. If a causal association can be established, KSHV could provide a model for the understanding of virus-induced neoplasia, like its cousin EBV. Although important questions regarding the specificity and temporality of KSHV and KS remain unanswered, the development and application of a sensitive serodiagnostic tool in longitudinal studies will be a crucial next step.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Herpesvirus Humano 8 , Sarcoma de Kaposi/epidemiología , Infecciones Oportunistas Relacionadas con el SIDA/virología , Animales , Humanos , Sarcoma de Kaposi/virologíaRESUMEN
BACKGROUND: Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is a newly discovered virus found in all forms of KS. In the United States, KSHV infection appears to be most common amongst individuals at high-risk for KS. Preliminary data from Africa suggest that KSHV infection may be much more common in the general population. OBJECTIVE: To examine the KSHV seroprevalence and age-specific patterns of infection in an African country with high rates of KS. DESIGN: Cross-sectional seroprevalence study. METHODS: Sera were taken for a hospital-based HIV seroprevalence study conducted in August 1985 in Lusaka, Zambia at a time when HIV was just becoming epidemic in this area. A total of 251 sera were randomly sampled and examined for antibodies against latent and lytic antigens to KSHV. KSHV seroprevalence was compared with demographic and clinical variables using chi2 test for linear trend and odds ratios and 95% confidence intervals. RESULTS: Overall, 58% of persons aged 14-84 years were KSHV-seropositive. KSHV seroprevalence increased linearly with age (P = 0.04) and was inversely related to years of education (P = 0.015). In contrast, HIV infection peaked in those aged 20-29 years and was positively related to years of education (P = 0.01 5). No association between KSHV and gender, marital status, or HIV serostatus was seen. CONCLUSIONS: KSHV infection was significantly more common in this region of Zambia in 1985 than it currently is in the United States. Our data are consistent with KSHV being well-established in this region prior to 1985 and that continued adult transmission of the virus was occurring. The high seroprevalence in the adolescent age-group and the relatively linear increase in prevalence with age suggest that non-sexual modes of transmission may be important for KSHV transmission in Africa.